RxDoctor Payments Data

Amy Harbin

Gerontology · Huntsville, ALNPI 1235665332

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Collegium Pharmaceutical, Inc. at 59.7% of the total.

$717in general payments, 2019–2025

Across 39 payments — averaging $18.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$428
  • AbbVie$79
  • Vertex$59
  • United Therapeutics Corporation$33
  • Almatica Pharma LLC$27
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$19
  • plus $71 from 4 others

What the payments were for

  • Food & beverage$717100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$717 in reported general payments places this provider in the 60th percentile of 143 gerontology providers in Alabama.

See all gerontology providers in Alabama

Medicare billing

Part B allowed, 2024
$37,020
Medicare patients
151
Services billed
737

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen654$10,617
LinzessLinaclotide13$6,673
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen129$2,256
Gabapentin133$1,558
Pregabalin64$1,337
Tizanidine Hcl99$1,150
Methocarbamol99$976
Lidocaine17$848
Duloxetine Hcl65$606
Celecoxib30$597
Cyclobenzaprine Hcl81$534
Diclofenac Sodium20$455
Oxycodone Hcl25$356
Meloxicam38$132
Tramadol Hcl36$120

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$79$6,67313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 143 gerontology providers in Alabama.

Other gerontology in Huntsville

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →